Resultados de procura - Yanan Kuang
- Mostrando 1 - 20 Resultados de 23
- Go to Next Page
-
1
Selective G Protein Coupling by C-C Chemokine Receptors por Yanan Kuang, Yanping Wu, Huiping Jiang, Dianqing Wu
Publicado 1996Artigo -
2
-
3
Roles of phospholipase C β2 in chemoattractant-elicited responses por Huiping Jiang, Yanan Kuang, Yanping Wu, Wei Xie, Melvin I. Simon, Dianqing Wu
Publicado 1997Artigo -
4
-
5
-
6
-
7
-
8
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer por Nicolas Guibert, Yuebi Hu, Nora Feeney, Yanan Kuang, Vincent Plagnol, Gregory R. Jones, Karen Howarth, John F. Beeler, Cloud P. Paweletz, Geoffrey R. Oxnard
Publicado 2018Artigo -
9
Noninvasive Detection of Response and Resistance in <i>EGFR</i>-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA por Geoffrey R. Oxnard, Cloud P. Paweletz, Yanan Kuang, Stacy L. Mach, Allison O’Connell, Melissa M. Messineo, Jason J. Luke, Mohit Butaney, Paul T. Kirschmeier, David M. Jackman, Pasi A. Jänne
Publicado 2014Artigo -
10
-
11
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients por Cloud P. Paweletz, Adrian G. Sacher, Chris K. Raymond, Ryan S. Alden, Allison O’Connell, Stacy L. Mach, Yanan Kuang, Leena Gandhi, Paul T. Kirschmeier, Jessie M. English, Lee P. Lim, Pasi A. Jänne, Geoffrey R. Oxnard
Publicado 2015Artigo -
12
Acquired <i>MET</i>D1228V Mutation and Resistance to MET Inhibition in Lung Cancer por Magda Bahcall, Taebo Sim, Cloud P. Paweletz, Jyoti D. Patel, Ryan S. Alden, Yanan Kuang, Adrian G. Sacher, Nam Doo Kim, Christine Lydon, Mark M. Awad, Michael T. Jaklitsch, Lynette M. Sholl, Pasi A. Jänne, Geoffrey R. Oxnard
Publicado 2016Artigo -
13
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors por César Serrano, Alessandro Leal, Yanan Kuang, Jeffrey A. Morgan, Constance M. Barysauskas, Jillian Phallen, Olivia Triplett, Adrián Mariño‐Enríquez, Andrew J. Wagner, George D. Demetri, Victor E. Velculescu, Cloud P. Paweletz, Jonathan A. Fletcher, Suzanne George
Publicado 2019Artigo -
14
Intratumoral Heterogeneity in <i>EGFR</i>-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition por Margaret Soucheray, Marzia Capelletti, Inés Pulido, Yanan Kuang, Cloud P. Paweletz, Jeffrey H. Becker, Eiki Kikuchi, Chunxiao Xu, Tarun B. Patel, Fátima Al‐Shahrour, Julián Carretero, Kwok‐Kin Wong, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura
Publicado 2015Artigo -
15
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer por Michalina Janiszewska, Lin Liu, Vanessa Almendro, Yanan Kuang, Cloud P. Paweletz, Rita A. Sakr, Britta Weigelt, Ariella B. Hanker, Sarat Chandarlapaty, Tari A. King, Jorge S. Reis‐Filho, Carlos L. Arteaga, So Yeon Park, Franziska Michor, Kornélia Polyák
Publicado 2015Artigo -
16
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M por Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard
Publicado 2015Artigo -
17
Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients por Cloud P. Paweletz, Grace A. Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C. Chao, Alexander I. Spira, Konstantinos Leventakos, Melissa L. Johnson, Sai‐Hong Ignatius Ou, Gregory J. Riely, Kenna Anderes, Wenjing Yang, James G. Christensen, Pasi A. Jänne
Publicado 2023Artigo -
18
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer por Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell, Gilles Buchwalter, Melissa E. Hughes, Nikhil Wagle, Paul Kirschmeier, Pasi A. Jänne, Cloud P. Paweletz, Nancy U. Lin, Ian E. Krop, William T. Barry, Eric P. Winer, Myles Brown, Rinath Jeselsohn
Publicado 2018Artigo -
19
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer por Jennifer Y. Ge, Shaokun Shu, Mijung Kwon, Bojana Jovanović, Katherine Murphy, Anushree C. Gulvady, Anne Fassl, Anne Trinh, Yanan Kuang, Grace A. Heavey, Adrienne Luoma, Cloud P. Paweletz, Aaron R. Thorner, Kai W. Wucherpfennig, Jun Qi, Myles Brown, Piotr Siciński, Thomas O. McDonald, David Pellman, Franziska Michor, Kornélia Polyák
Publicado 2020Artigo -
20
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance por Rinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, Gilles Buchwalter, Mai Q. Nguyen, Clyde Bango, Ying Huang, Yanan Kuang, Cloud P. Paweletz, Xiaoyong Fu, Agostina Nardone, Carmine De Angelis, Simone Detre, Andrew Dodson, Hisham Mohammed, Jason S. Carroll, Michaela Bowden, Prakash K. Rao, Henry W. Long, Fugen Li, Mitch Dowsett, Rachel Schiff, Myles Brown
Publicado 2017Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Cancer
Cancer research
Genetics
Gene
Internal medicine
Oncology
Lung cancer
Biochemistry
Mutation
Epidermal growth factor receptor
Polymerase chain reaction
Receptor
Breast cancer
Cell-free fetal DNA
Digital polymerase chain reaction
Erlotinib
Fetus
Immunology
Pharmacology
Pregnancy
Prenatal diagnosis
T790M
Cell biology
Chemistry
Colorectal cancer
Drug resistance
Gefitinib
Genotype